Medical Pharmaceuticals Headlines from PR Newswire

< Go Back

QT Vascular Announces Acquisition of Novel Technology for Interventional Treatment
Synchrogenix Appoints Two New Global Submissions Directors
Imaging in 2020 Conference Focuses on Imaging the Immune System to Improve the Diagnosis and Treatment of Cancer, Heart Disease and Brain Disorders
Surviving Members Of Balatbat Family, Killed By Tornado In July, Receive Donation From BioReference Laboratories
Upsher-Smith Presents New Data On The Administration Of Qudexy™ XR (Topiramate) Extended-Release Capsules Through Enteral Feeding Tubes
Global Nuclear Medicine Imaging Equipment - Strategic Business Report 2014
Ringgold County Hospital Improves Workflow with Avreo interWORKS
Life Extension Foundation supported study demonstrates cognitive benefits of green tea extract in Down syndrome
The Hope Murals Project National Art Movement Culminates in Painting Event at Grand Central Terminal on October 23
SPDT Approved for use in Indiana Cancer Treatment Center
Data Presented at the International Society of Paediatric Oncology (SIOP) Congress Show Palonosetron is a Valuable Option for Treating Pediatric Patients Receiving Moderately to Highly Emetogenic Chemotherapy
Metabolic Solutions Development Company Appoints Robert L. Zerbe, MD to Board of Managers
Generex / Antigen Express to Participate in 2014 BIO-Europe® Annual International Partnering Conference
CHEST Foundation Launches Campaign to Encourage People With COPD to Live Well
Neuralstem Alzheimer's Disease Animal Data Presented At The Congress Of Neurological Surgeons Annual Meeting
Rock Creek Pharmaceuticals Announces Presentation of Four Anatabine Projects at Neuroscience 2014
AbVitro Inc. Appoints Jeffrey M. Ostrove, Ph.D. as Chief Executive Officer
Phreesia Secures $30 Million in Funding Led by LLR Partners to Continue Expansive Growth and Maintain Market Leadership
Boston Children's names three finalists for "Innovation Tank" competition
Ameritox to Present Clinical Research to Forensic Toxicology Scientific Community
Resonetics Recapitalizes with Sverica International
Perrigo Company plc To Release First Quarter Fiscal Year 2015 Results On November 6, 2014
CryoLife Announces Quarterly Cash Dividend for the Fourth Quarter 2014
TPI's QLF Updates on its GMP Certification Progress
Abaxis Announces Appointment of Ross Taylor as Vice President of Business Development & Investor Relations
Cantel Medical Named to the Forbes 2014 List of the "100 Best Small Companies in America"
Gaia Herbs® Invited to Present at U.S. Pharmacopeial Convention Meeting October 23-24
StaffDNA Gives Healthcare Employers Ability to Find Healthcare Talent
Kalorama: IVD Industry Responds to Ebola Outbreak With Point of Care Tests
Cutting Edge Genomic MS Research Earns Philip De Jager, MD, PhD, of Brigham and Women's Hospital / Harvard Medical School the 2014 Barancik Prize for Innovation in Multiple Sclerosis Research
Global Bio-Implants Market is Expected to Reach to $115.8 billion by 2020- Allied Market Research
Arrowhead Health Centers of Arizona Offers Leading Multimodal OsteoArthritis Treatment Program
Gaumard® Scientific Installs Victoria™ Birthing Simulator at Health Care Educational Facilities in Colorado and Michigan
Seno Medical Instruments to Present at the Cleveland Clinic's 12th Annual Medical Innovation Summit
Actavis Confirms Appeals Court Upholds Lo Loestrin® Fe Patent
MabVax Therapeutics Launches Online Corporate Communication Channels and New Website
UK's NHS Supply Chain Selects 10 TrueBeam Treatment Machines to Enable More Advanced Cancer Treatments
Zimmer Holdings, Inc. Reports Third Quarter 2014 Financial Results
Hyaluronic Acid Market (Glass Acid) - 9.14% CAGR Forecast Globally to 2018
Cannabis Kinetics Analyst Coverage Initiated: Green-Light of State's Legalization by BrokerBank Securities, Inc.
Sutro Biopharma and Celgene Corporation Enter Multi-Year Strategic Collaboration and Option to Acquire Agreement
Global Oral Hygiene Market 2014-2018: Key Vendors are Colgate-Palmolive, GlaxoSmithKline, Johnson & Johnson and Procter & Gamble
Henry Schein To Webcast Third Quarter 2014 Conference Call On Thursday, November 6, 2014 At 10:00 A.M. ET
NeuroDerm Announces Presentation of ND0612L Top-line Phase II Results and ND0612H Preliminary Interim Phase IIa Results at the 2014 Parkinson's Disease Therapeutics Conference
Orexigen Therapeutics Analyst Coverage Initiated with Price Target by BrokerBank Securities, Inc.
Quest Diagnostics Reports Third Quarter 2014 Financial Results
STAAR Surgical Announces Third Quarter 2014 Results Release Date, Conference Call And Webcast
NeoGenomics is First to Offer Molecular Testing for Resistance to Bruton Tyrosin Kinase Inhibitors for Chronic Lymphocytic Leukemia
Lilly Reports Third-Quarter 2014 Results
EasyOne Plus Mobile Pulmonary Testing Device to Screen for COPD at Austin Lung Health Day October 27

< Prev Next >
PR Newswire - United Business Media